机译:Lenalidomide在预处理的弥漫性大B细胞淋巴瘤患者:每日临床实践中的意大利观察多中心回顾性研究
Institute of Hematology University of BolognaBologna Italy;
Institute of Hematology University of BolognaBologna Italy;
Hematology Città della Salute e della Scienza Hospital and UniversityTorino Italy;
Department of Cell Therapy and Hematology San Bortolo HospitalVicenza Italy;
Hematology Unit S. Maria delle Croci HospitalRavenna Italy;
Hematology Department “Casa Sollievo della Sofferenza” HospitalIRCCS – Italy;
Hematology Division Ospedale degli Infermi di BiellaPonderano Italy;
Departmento of Medical Oncology and Hematology Humanitas Cancer CenterRozzano‐Milan Italy;
Hematology unit Azienda ospedaliera universitaria Sant'AndreaRome Italy;
Dipartimento di Oncologia Clinica e Sperimentale Oncologia Medica 1 Istituto Oncologico Veneto;
Hematology Department IRCCS “Ospedale Maggiore Policlinico” MilanItaly;
Department of Medical Sciences Section of Hematology University of Modena and Reggio EmiliaModena;
Hematology and Bone Marrow Transplant Unit Verona UniversityVerona Italy;
Department of Hematology Azienda Ospedali Riuniti Villa Sofia‐ CervelloPalermo Italy;
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCSMeldola Italy;
Division of Hematology IRCCS Istituto Nazionale dei TumoriMilan Italy;
Hematology Unit SS Antonio e Biagio e Cesare ArrigoAlessandria Italy;
Division of Hematology AOU Policlinico‐OVE Department of Surgery and Medical Specialties;
Hematology AUSL‐IRCCSReggio Emilia Italy;
Division of Hematology ASST Niguarda HospitalMilan Italy;
Rovigo's Hematology DepartmentRovigo Italy;
Hematology AOU CareggiFirenze Italy;
Azienda Ospedaliera S. Croce e Carle ‐ Hematology Department and BMT UnitCuneo Italy;
Unit of Hematology with Transplantation Department of Emergency and Organ Transplantation;
Institute of Hematology University of BolognaBologna Italy;
Institute of Hematology University of BolognaBologna Italy;
Lenalidomide; Diffuse large B‐cell lymphoma; Relapsed; Refractory; Real life;
机译:Lenalidomide在预处理的弥漫性大B细胞淋巴瘤患者:每日临床实践中的意大利观察多中心回顾性研究
机译:来那度胺在预处理的套细胞淋巴瘤患者中的应用:每日临床实践中的意大利多中心观察性回顾性研究(Lenamant研究)
机译:Lenalidomide在预处理的地幔细胞淋巴瘤患者:日常临床实践中的意大利观察多中心回顾性研究(烯醇研究)
机译:患者弥漫性大B细胞淋巴瘤细胞株和血清中microRNA-21的表达及临床意义
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:来那度胺治疗弥漫性大B细胞淋巴瘤的预处理患者:日常临床实践中的意大利观察性多中心回顾性研究。
机译:Lenalidomide在预处理的弥漫性大B细胞淋巴瘤患者中:一种意大利观测的多中心回顾性研究日常临床实践